This was made known in a statement issued by the Director-General of the agency, Prof. Mojisola Adeyeye.
She said NAFDAC was notified by the World Health Organisation of the circulation of the tablets in Cameroon.
“The falsified chloroquine phosphate 250mg tablets were manufactured by Jiangsu pharmaceutical Inc, Astral pharmaceutical New Bhupalpura, China.
“The tablets manufactured by these companies have no Active Pharmaceutical Ingredient (API) and are in packs of 1000 tablets.
“The use of the falsified chloroquine phosphate 250mg tablets may result in treatment failure and could even cause death,” she…